Notice of AGM

RNS Number : 4023Q
First Derivatives PLC
05 June 2018
 

5 June 2018

 

First Derivatives plc

("FD" or the "Group")

 

Annual Report 2017/18 and AGM Notice

 

FD (AIM: FDP.L, ESM: FDP.I) announces that a copy of its annual report for the financial year ending 28 February 2018 has been posted to all shareholders. It is also available on the Group website at www.firstderivatives.com.

 

The Annual General Meeting will be held at 10am on 27 June 2018 at the Group's Head Office at 3 Canal Quay, Newry, County Down BT35 6BP.

 

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0) 20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 (0)1 667 0420

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

Niamh Fogarty

 

+44 (0) 20 3727 1000

About FD

FD is a global technology provider with 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 14 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,200 people worldwide.  

 

For further information, please visit www.firstderivatives.com and www.kx.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAFAMATMBAMBMP
UK 100

Latest directors dealings